534 related articles for article (PubMed ID: 31328345)
1. Pharmacotherapy for methamphetamine/amphetamine use disorder-a systematic review and meta-analysis.
Chan B; Freeman M; Kondo K; Ayers C; Montgomery J; Paynter R; Kansagara D
Addiction; 2019 Dec; 114(12):2122-2136. PubMed ID: 31328345
[TBL] [Abstract][Full Text] [Related]
2. Pharmacotherapy for Cocaine Use Disorder-a Systematic Review and Meta-analysis.
Chan B; Kondo K; Freeman M; Ayers C; Montgomery J; Kansagara D
J Gen Intern Med; 2019 Dec; 34(12):2858-2873. PubMed ID: 31183685
[TBL] [Abstract][Full Text] [Related]
3. A systematic review and meta-analysis of medications for stimulant use disorders in patients with co-occurring opioid use disorders.
Chan B; Freeman M; Ayers C; Korthuis PT; Paynter R; Kondo K; Kansagara D
Drug Alcohol Depend; 2020 Nov; 216():108193. PubMed ID: 32861136
[TBL] [Abstract][Full Text] [Related]
4. Pharmacological Treatment of Methamphetamine/Amphetamine Dependence: A Systematic Review.
Siefried KJ; Acheson LS; Lintzeris N; Ezard N
CNS Drugs; 2020 Apr; 34(4):337-365. PubMed ID: 32185696
[TBL] [Abstract][Full Text] [Related]
5. Pharmacotherapy for amphetamine dependence: A systematic review.
Lee NK; Jenner L; Harney A; Cameron J
Drug Alcohol Depend; 2018 Oct; 191():309-337. PubMed ID: 30173086
[TBL] [Abstract][Full Text] [Related]
6. Antipsychotics for cocaine or psychostimulant dependence: systematic review and meta-analysis of randomized, placebo-controlled trials.
Kishi T; Matsuda Y; Iwata N; Correll CU
J Clin Psychiatry; 2013 Dec; 74(12):e1169-80. PubMed ID: 24434105
[TBL] [Abstract][Full Text] [Related]
7. Sustained-release methylphenidate in a randomized trial of treatment of methamphetamine use disorder.
Ling W; Chang L; Hillhouse M; Ang A; Striebel J; Jenkins J; Hernandez J; Olaer M; Mooney L; Reed S; Fukaya E; Kogachi S; Alicata D; Holmes N; Esagoff A
Addiction; 2014 Sep; 109(9):1489-500. PubMed ID: 24825486
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and safety of naltrexone for amfetamine and methamfetamine use disorder: a systematic review of randomized controlled trials.
Lam L; Anand S; Li X; Tse ML; Zhao JX; Chan EW
Clin Toxicol (Phila); 2019 Apr; 57(4):225-233. PubMed ID: 30451013
[TBL] [Abstract][Full Text] [Related]
9. Prescription psychostimulants for the treatment of stimulant use disorder: a systematic review and meta-analysis.
Tardelli VS; Bisaga A; Arcadepani FB; Gerra G; Levin FR; Fidalgo TM
Psychopharmacology (Berl); 2020 Aug; 237(8):2233-2255. PubMed ID: 32601988
[TBL] [Abstract][Full Text] [Related]
10. Utilizing a Two-stage Design to Investigate the Safety and Potential Efficacy of Monthly Naltrexone Plus Once-daily Bupropion as a Treatment for Methamphetamine Use Disorder.
Mooney LJ; Hillhouse MP; Thomas C; Ang A; Sharma G; Terry G; Chang L; Walker R; Trivedi M; Croteau D; Sparenborg S; Ling W
J Addict Med; 2016; 10(4):236-43. PubMed ID: 27379819
[TBL] [Abstract][Full Text] [Related]
11. Prescription psychostimulants for the treatment of amphetamine-type stimulant use disorder: A systematic review and meta-analysis of randomized placebo-controlled trials.
Sharafi H; Bakouni H; McAnulty C; Drouin S; Coronado-Montoya S; Bahremand A; Bach P; Ezard N; Le Foll B; Schütz CG; Siefried KJ; Tardelli VS; Ziegler D; Jutras-Aswad D
Addiction; 2024 Feb; 119(2):211-224. PubMed ID: 37880829
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and safety of psychostimulants for amphetamine and methamphetamine use disorders: a systematic review and meta-analysis.
Bhatt M; Zielinski L; Baker-Beal L; Bhatnagar N; Mouravska N; Laplante P; Worster A; Thabane L; Samaan Z
Syst Rev; 2016 Nov; 5(1):189. PubMed ID: 27842569
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of psychostimulant drugs for amphetamine abuse or dependence.
Pérez-Mañá C; Castells X; Torrens M; Capellà D; Farre M
Cochrane Database Syst Rev; 2013 Sep; (9):CD009695. PubMed ID: 23996457
[TBL] [Abstract][Full Text] [Related]
14. Dropout in clinical trials of pharmacological treatment for methamphetamine dependence: the role of initial abstinence.
Cook R; Quinn B; Heinzerling K; Shoptaw S
Addiction; 2017 Jun; 112(6):1077-1085. PubMed ID: 28107598
[TBL] [Abstract][Full Text] [Related]
15. Association of Pharmacological Treatments and Hospitalization and Death in Individuals With Amphetamine Use Disorders in a Swedish Nationwide Cohort of 13 965 Patients.
Hartikainen M; Taipale H; Tanskanen A; Mittendorfer-Rutz E; Lähteenvuo M; Tiihonen J
JAMA Psychiatry; 2023 Jan; 80(1):31-39. PubMed ID: 36383348
[TBL] [Abstract][Full Text] [Related]
16. Impact of prospectively determined A118G polymorphism on treatment response to injectable naltrexone among methamphetamine-dependent patients: an open-label, pilot study.
Pal R; Mendelson JE; Flower K; Garrison K; Yount G; Coyle JR; Galloway GP
J Addict Med; 2015; 9(2):130-5. PubMed ID: 25622123
[TBL] [Abstract][Full Text] [Related]
17. Treatment of amphetamine abuse/use disorder: a systematic review of a recent health concern.
Khoramizadeh M; Effatpanah M; Mostaghimi A; Rezaei M; Mahjoub A; Shishehgar S
Daru; 2019 Dec; 27(2):743-753. PubMed ID: 31228128
[TBL] [Abstract][Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
